Literature DB >> 32387127

Diagnosis and differential diagnosis of diabetes insipidus: Update.

Julie Refardt1.   

Abstract

The two main differential diagnoses of central diabetes insipidus are nephrogenic diabetes insipidus and primary polydipsia. Reliable distinction between those entities is essential as treatment differs substantially with the wrong treatment potentially leading to serious complications. Past diagnostic measures using the indirect water deprivation test had several pitfalls, resulting in a low diagnostic accuracy. With the introduction of copeptin, a stable and reliable surrogate marker for arginine vasopressin, diagnosis of diabetes insipidus was new evaluated. While unstimulated basal copeptin measurement reliably diagnoses nephrogenic diabetes insipidus, a stimulation test is needed to differentiate patients with central diabetes insipidus from patients with primary polydipsia. Stimulation can either be achieved through hypertonic saline infusion or arginine infusion. While the former showed high diagnostic accuracy and superiority over the indirect water deprivation test in a recent validation study, the diagnostic accuracy for arginine-stimulated copeptin was slightly lower, but superior in test tolerance. In summary of the recent findings, a new copeptin based diagnostic algorithm is proposed for the reliable diagnosis of diabetes insipidus.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  copeptin; diabetes insipidus; diagnosis; polyuria-polydipsia syndrome; primary polydipsia

Mesh:

Substances:

Year:  2020        PMID: 32387127     DOI: 10.1016/j.beem.2020.101398

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  9 in total

Review 1.  Diagnosis and Management of Central Diabetes Insipidus in Adults.

Authors:  Maria Tomkins; Sarah Lawless; Julie Martin-Grace; Mark Sherlock; Chris J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

2.  Gut microbiota profiling revealed the regulating effects of salidroside on iron metabolism in diabetic mice.

Authors:  Jing Shi; Qin Zhao; Dou Dou Hao; Hong Xia Miao; Sha Wan; Chao Hua Zhou; Si Yu Wang; Si Yuan Chen; Jin Shang; Tian Hang Feng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

3.  Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study.

Authors:  H Masri Iraqi; E Pigarova; S Zacharieva; A Colao; L Baraf; M Tsoli; M Doknic; S Ricci Bitti; R Giordano; M Barbot; A Akirov; P Witek; M Serebro; M K Auer; M Tóth; I Shimon
Journal:  Pituitary       Date:  2022-10-19       Impact factor: 3.599

4.  Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene.

Authors:  Maria Inês Alvelos; Ângela Francisco; Leonor Gomes; Isabel Paiva; Miguel Melo; Pedro Marques; Susana Gama-de-Sousa; Sofia Carreiro; Telma Quintela; Isabel Gonçalves; Manuel Carlos Lemos
Journal:  Pituitary       Date:  2021-01-12       Impact factor: 4.107

5.  Iatrogenic Hypothalamus Injury After Resection of Subependymoma Within the Left Brain Ventricle.

Authors:  Jing Bao; Zhenjiang Pan; Shepeng Wei
Journal:  Cureus       Date:  2021-01-31

Review 6.  Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management.

Authors:  Cody M Mutter; Trevor Smith; Olivia Menze; Mariah Zakharia; Hoang Nguyen
Journal:  Cureus       Date:  2021-02-23

7.  Central diabetes insipidus after total abdominal hysterectomy and bilateral salpingo-oophrectomy: A case report.

Authors:  Aarti Maharaj; Kundan Jana; Brent Boodhai; Kalyana C Janga; Elie Fein; Sheldon Greenberg
Journal:  Clin Case Rep       Date:  2022-03-17

8.  A Diagnostic Enigma of Central Versus Nephrogenic Diabetes Insipidus: What Does the Value of Copeptin Signify?

Authors:  Dhan B Shrestha; Ranjit B Jasaraj; Roman Dhital; Esho Georges; Andriy Havrylyan
Journal:  Cureus       Date:  2022-02-26

9.  The Variation of Transcriptomic Perturbations is Associated with the Development and Progression of Various Diseases.

Authors:  Zehua Dong; Qiyu Yan; Xiaosheng Wang
Journal:  Dis Markers       Date:  2022-09-26       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.